0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dermatological Medicine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-3E12989
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dermatological Medicine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Dermatological Medicine Market Research Report 2025

Code: QYRE-Auto-3E12989
Report
July 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dermatological Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Dermatological Medicine Market

Dermatological Medicine Market

The global market for Dermatological Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The Dermatological Medicines are concerned with the treatment and prevention of the diseases of the skin, hairs, nails, oral cavity and genitals.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermatological Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Medicine.
The Dermatological Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dermatological Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dermatological Medicine Market Report

Report Metric Details
Report Name Dermatological Medicine Market
CAGR 5%
Segment by Type
  • Anti-infectives
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoids
  • Others
Segment by Application
  • Alopecia
  • Herpes
  • Psoriasis
  • Rosacea
  • Atopic Dermatitis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson and Johnson, GSK, Pfizer, AbbVie, Bayer, Merck, Reckitt Benckiser, Taisho Pharmaceutical, Perrigo, Ikeda Mohando, DermaPharm A/S, LEO Pharma, China Resources Pharmaceutical Group, Chongqing Huapont Pharm Co., Bright Future Pharmaceutical, Xiuzheng Pharmaceutical Group, China National Pharmaceutical Group, Harbin Letai, Hebei Xinglong Xili Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dermatological Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dermatological Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dermatological Medicine Market report?

Ans: The main players in the Dermatological Medicine Market are Johnson and Johnson, GSK, Pfizer, AbbVie, Bayer, Merck, Reckitt Benckiser, Taisho Pharmaceutical, Perrigo, Ikeda Mohando, DermaPharm A/S, LEO Pharma, China Resources Pharmaceutical Group, Chongqing Huapont Pharm Co., Bright Future Pharmaceutical, Xiuzheng Pharmaceutical Group, China National Pharmaceutical Group, Harbin Letai, Hebei Xinglong Xili Pharmaceutical

What are the Application segmentation covered in the Dermatological Medicine Market report?

Ans: The Applications covered in the Dermatological Medicine Market report are Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Others

What are the Type segmentation covered in the Dermatological Medicine Market report?

Ans: The Types covered in the Dermatological Medicine Market report are Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Others

1 Dermatological Medicine Market Overview
1.1 Product Definition
1.2 Dermatological Medicine by Type
1.2.1 Global Dermatological Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anti-infectives
1.2.3 Corticosteroids
1.2.4 Anti-acne
1.2.5 Calcineurin Inhibitors
1.2.6 Retinoids
1.2.7 Others
1.3 Dermatological Medicine by Application
1.3.1 Global Dermatological Medicine Market Value by Application (2024 VS 2031)
1.3.2 Alopecia
1.3.3 Herpes
1.3.4 Psoriasis
1.3.5 Rosacea
1.3.6 Atopic Dermatitis
1.3.7 Others
1.4 Global Dermatological Medicine Market Size Estimates and Forecasts
1.4.1 Global Dermatological Medicine Revenue 2020-2031
1.4.2 Global Dermatological Medicine Sales 2020-2031
1.4.3 Global Dermatological Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dermatological Medicine Market Competition by Manufacturers
2.1 Global Dermatological Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dermatological Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dermatological Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dermatological Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermatological Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermatological Medicine, Product Type & Application
2.7 Global Key Manufacturers of Dermatological Medicine, Date of Enter into This Industry
2.8 Global Dermatological Medicine Market Competitive Situation and Trends
2.8.1 Global Dermatological Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dermatological Medicine Players Market Share by Revenue
2.8.3 Global Dermatological Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dermatological Medicine Market Scenario by Region
3.1 Global Dermatological Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dermatological Medicine Sales by Region: 2020-2031
3.2.1 Global Dermatological Medicine Sales by Region: 2020-2025
3.2.2 Global Dermatological Medicine Sales by Region: 2026-2031
3.3 Global Dermatological Medicine Revenue by Region: 2020-2031
3.3.1 Global Dermatological Medicine Revenue by Region: 2020-2025
3.3.2 Global Dermatological Medicine Revenue by Region: 2026-2031
3.4 North America Dermatological Medicine Market Facts & Figures by Country
3.4.1 North America Dermatological Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dermatological Medicine Sales by Country (2020-2031)
3.4.3 North America Dermatological Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dermatological Medicine Market Facts & Figures by Country
3.5.1 Europe Dermatological Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dermatological Medicine Sales by Country (2020-2031)
3.5.3 Europe Dermatological Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermatological Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Dermatological Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dermatological Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Dermatological Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dermatological Medicine Market Facts & Figures by Country
3.7.1 Latin America Dermatological Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dermatological Medicine Sales by Country (2020-2031)
3.7.3 Latin America Dermatological Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermatological Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermatological Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dermatological Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dermatological Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dermatological Medicine Sales by Type (2020-2031)
4.1.1 Global Dermatological Medicine Sales by Type (2020-2025)
4.1.2 Global Dermatological Medicine Sales by Type (2026-2031)
4.1.3 Global Dermatological Medicine Sales Market Share by Type (2020-2031)
4.2 Global Dermatological Medicine Revenue by Type (2020-2031)
4.2.1 Global Dermatological Medicine Revenue by Type (2020-2025)
4.2.2 Global Dermatological Medicine Revenue by Type (2026-2031)
4.2.3 Global Dermatological Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Dermatological Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dermatological Medicine Sales by Application (2020-2031)
5.1.1 Global Dermatological Medicine Sales by Application (2020-2025)
5.1.2 Global Dermatological Medicine Sales by Application (2026-2031)
5.1.3 Global Dermatological Medicine Sales Market Share by Application (2020-2031)
5.2 Global Dermatological Medicine Revenue by Application (2020-2031)
5.2.1 Global Dermatological Medicine Revenue by Application (2020-2025)
5.2.2 Global Dermatological Medicine Revenue by Application (2026-2031)
5.2.3 Global Dermatological Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Dermatological Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Company Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson and Johnson Dermatological Medicine Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Dermatological Medicine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Dermatological Medicine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie Dermatological Medicine Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Dermatological Medicine Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Dermatological Medicine Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Reckitt Benckiser
6.7.1 Reckitt Benckiser Company Information
6.7.2 Reckitt Benckiser Description and Business Overview
6.7.3 Reckitt Benckiser Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Reckitt Benckiser Dermatological Medicine Product Portfolio
6.7.5 Reckitt Benckiser Recent Developments/Updates
6.8 Taisho Pharmaceutical
6.8.1 Taisho Pharmaceutical Company Information
6.8.2 Taisho Pharmaceutical Description and Business Overview
6.8.3 Taisho Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Taisho Pharmaceutical Dermatological Medicine Product Portfolio
6.8.5 Taisho Pharmaceutical Recent Developments/Updates
6.9 Perrigo
6.9.1 Perrigo Company Information
6.9.2 Perrigo Description and Business Overview
6.9.3 Perrigo Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Perrigo Dermatological Medicine Product Portfolio
6.9.5 Perrigo Recent Developments/Updates
6.10 Ikeda Mohando
6.10.1 Ikeda Mohando Company Information
6.10.2 Ikeda Mohando Description and Business Overview
6.10.3 Ikeda Mohando Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ikeda Mohando Dermatological Medicine Product Portfolio
6.10.5 Ikeda Mohando Recent Developments/Updates
6.11 DermaPharm A/S
6.11.1 DermaPharm A/S Company Information
6.11.2 DermaPharm A/S Description and Business Overview
6.11.3 DermaPharm A/S Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 DermaPharm A/S Dermatological Medicine Product Portfolio
6.11.5 DermaPharm A/S Recent Developments/Updates
6.12 LEO Pharma
6.12.1 LEO Pharma Company Information
6.12.2 LEO Pharma Description and Business Overview
6.12.3 LEO Pharma Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LEO Pharma Dermatological Medicine Product Portfolio
6.12.5 LEO Pharma Recent Developments/Updates
6.13 China Resources Pharmaceutical Group
6.13.1 China Resources Pharmaceutical Group Company Information
6.13.2 China Resources Pharmaceutical Group Description and Business Overview
6.13.3 China Resources Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio
6.13.5 China Resources Pharmaceutical Group Recent Developments/Updates
6.14 Chongqing Huapont Pharm Co.
6.14.1 Chongqing Huapont Pharm Co. Company Information
6.14.2 Chongqing Huapont Pharm Co. Description and Business Overview
6.14.3 Chongqing Huapont Pharm Co. Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio
6.14.5 Chongqing Huapont Pharm Co. Recent Developments/Updates
6.15 Bright Future Pharmaceutical
6.15.1 Bright Future Pharmaceutical Company Information
6.15.2 Bright Future Pharmaceutical Description and Business Overview
6.15.3 Bright Future Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bright Future Pharmaceutical Dermatological Medicine Product Portfolio
6.15.5 Bright Future Pharmaceutical Recent Developments/Updates
6.16 Xiuzheng Pharmaceutical Group
6.16.1 Xiuzheng Pharmaceutical Group Company Information
6.16.2 Xiuzheng Pharmaceutical Group Description and Business Overview
6.16.3 Xiuzheng Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio
6.16.5 Xiuzheng Pharmaceutical Group Recent Developments/Updates
6.17 China National Pharmaceutical Group
6.17.1 China National Pharmaceutical Group Company Information
6.17.2 China National Pharmaceutical Group Description and Business Overview
6.17.3 China National Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 China National Pharmaceutical Group Dermatological Medicine Product Portfolio
6.17.5 China National Pharmaceutical Group Recent Developments/Updates
6.18 Harbin Letai
6.18.1 Harbin Letai Company Information
6.18.2 Harbin Letai Description and Business Overview
6.18.3 Harbin Letai Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Harbin Letai Dermatological Medicine Product Portfolio
6.18.5 Harbin Letai Recent Developments/Updates
6.19 Hebei Xinglong Xili Pharmaceutical
6.19.1 Hebei Xinglong Xili Pharmaceutical Company Information
6.19.2 Hebei Xinglong Xili Pharmaceutical Description and Business Overview
6.19.3 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio
6.19.5 Hebei Xinglong Xili Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermatological Medicine Industry Chain Analysis
7.2 Dermatological Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermatological Medicine Production Mode & Process Analysis
7.4 Dermatological Medicine Sales and Marketing
7.4.1 Dermatological Medicine Sales Channels
7.4.2 Dermatological Medicine Distributors
7.5 Dermatological Medicine Customer Analysis
8 Dermatological Medicine Market Dynamics
8.1 Dermatological Medicine Industry Trends
8.2 Dermatological Medicine Market Drivers
8.3 Dermatological Medicine Market Challenges
8.4 Dermatological Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dermatological Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dermatological Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dermatological Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dermatological Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dermatological Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dermatological Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dermatological Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dermatological Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dermatological Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dermatological Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dermatological Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Dermatological Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dermatological Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dermatological Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dermatological Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dermatological Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Dermatological Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dermatological Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Dermatological Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dermatological Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Dermatological Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dermatological Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Dermatological Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dermatological Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dermatological Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dermatological Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dermatological Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dermatological Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dermatological Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dermatological Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dermatological Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dermatological Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dermatological Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dermatological Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dermatological Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dermatological Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dermatological Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dermatological Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dermatological Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dermatological Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dermatological Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dermatological Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dermatological Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dermatological Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dermatological Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dermatological Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dermatological Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dermatological Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Dermatological Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Dermatological Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Dermatological Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Dermatological Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dermatological Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dermatological Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Dermatological Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Dermatological Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dermatological Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dermatological Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Dermatological Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Dermatological Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Dermatological Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Dermatological Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dermatological Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dermatological Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Dermatological Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Dermatological Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dermatological Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson and Johnson Company Information
 Table 71. Johnson and Johnson Description and Business Overview
 Table 72. Johnson and Johnson Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson and Johnson Dermatological Medicine Product
 Table 74. Johnson and Johnson Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Dermatological Medicine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Dermatological Medicine Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. AbbVie Company Information
 Table 86. AbbVie Description and Business Overview
 Table 87. AbbVie Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AbbVie Dermatological Medicine Product
 Table 89. AbbVie Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer Dermatological Medicine Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Merck Dermatological Medicine Product
 Table 99. Merck Recent Developments/Updates
 Table 100. Reckitt Benckiser Company Information
 Table 101. Reckitt Benckiser Description and Business Overview
 Table 102. Reckitt Benckiser Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Reckitt Benckiser Dermatological Medicine Product
 Table 104. Reckitt Benckiser Recent Developments/Updates
 Table 105. Taisho Pharmaceutical Company Information
 Table 106. Taisho Pharmaceutical Description and Business Overview
 Table 107. Taisho Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Taisho Pharmaceutical Dermatological Medicine Product
 Table 109. Taisho Pharmaceutical Recent Developments/Updates
 Table 110. Perrigo Company Information
 Table 111. Perrigo Description and Business Overview
 Table 112. Perrigo Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Perrigo Dermatological Medicine Product
 Table 114. Perrigo Recent Developments/Updates
 Table 115. Ikeda Mohando Company Information
 Table 116. Ikeda Mohando Description and Business Overview
 Table 117. Ikeda Mohando Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ikeda Mohando Dermatological Medicine Product
 Table 119. Ikeda Mohando Recent Developments/Updates
 Table 120. DermaPharm A/S Company Information
 Table 121. DermaPharm A/S Description and Business Overview
 Table 122. DermaPharm A/S Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. DermaPharm A/S Dermatological Medicine Product
 Table 124. DermaPharm A/S Recent Developments/Updates
 Table 125. LEO Pharma Company Information
 Table 126. LEO Pharma Description and Business Overview
 Table 127. LEO Pharma Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. LEO Pharma Dermatological Medicine Product
 Table 129. LEO Pharma Recent Developments/Updates
 Table 130. China Resources Pharmaceutical Group Company Information
 Table 131. China Resources Pharmaceutical Group Description and Business Overview
 Table 132. China Resources Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. China Resources Pharmaceutical Group Dermatological Medicine Product
 Table 134. China Resources Pharmaceutical Group Recent Developments/Updates
 Table 135. Chongqing Huapont Pharm Co. Company Information
 Table 136. Chongqing Huapont Pharm Co. Description and Business Overview
 Table 137. Chongqing Huapont Pharm Co. Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Chongqing Huapont Pharm Co. Dermatological Medicine Product
 Table 139. Chongqing Huapont Pharm Co. Recent Developments/Updates
 Table 140. Bright Future Pharmaceutical Company Information
 Table 141. Bright Future Pharmaceutical Description and Business Overview
 Table 142. Bright Future Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Bright Future Pharmaceutical Dermatological Medicine Product
 Table 144. Bright Future Pharmaceutical Recent Developments/Updates
 Table 145. Xiuzheng Pharmaceutical Group Company Information
 Table 146. Xiuzheng Pharmaceutical Group Description and Business Overview
 Table 147. Xiuzheng Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Xiuzheng Pharmaceutical Group Dermatological Medicine Product
 Table 149. Xiuzheng Pharmaceutical Group Recent Developments/Updates
 Table 150. China National Pharmaceutical Group Company Information
 Table 151. China National Pharmaceutical Group Description and Business Overview
 Table 152. China National Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. China National Pharmaceutical Group Dermatological Medicine Product
 Table 154. China National Pharmaceutical Group Recent Developments/Updates
 Table 155. Harbin Letai Company Information
 Table 156. Harbin Letai Description and Business Overview
 Table 157. Harbin Letai Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Harbin Letai Dermatological Medicine Product
 Table 159. Harbin Letai Recent Developments/Updates
 Table 160. Hebei Xinglong Xili Pharmaceutical Company Information
 Table 161. Hebei Xinglong Xili Pharmaceutical Description and Business Overview
 Table 162. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product
 Table 164. Hebei Xinglong Xili Pharmaceutical Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Dermatological Medicine Distributors List
 Table 168. Dermatological Medicine Customers List
 Table 169. Dermatological Medicine Market Trends
 Table 170. Dermatological Medicine Market Drivers
 Table 171. Dermatological Medicine Market Challenges
 Table 172. Dermatological Medicine Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dermatological Medicine
 Figure 2. Global Dermatological Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dermatological Medicine Market Share by Type: 2024 & 2031
 Figure 4. Anti-infectives Product Picture
 Figure 5. Corticosteroids Product Picture
 Figure 6. Anti-acne Product Picture
 Figure 7. Calcineurin Inhibitors Product Picture
 Figure 8. Retinoids Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Dermatological Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Dermatological Medicine Market Share by Application: 2024 & 2031
 Figure 12. Alopecia
 Figure 13. Herpes
 Figure 14. Psoriasis
 Figure 15. Rosacea
 Figure 16. Atopic Dermatitis
 Figure 17. Others
 Figure 18. Global Dermatological Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Dermatological Medicine Market Size (2020-2031) & (US$ Million)
 Figure 20. Global Dermatological Medicine Sales (2020-2031) & (K Units)
 Figure 21. Global Dermatological Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 22. Dermatological Medicine Report Years Considered
 Figure 23. Dermatological Medicine Sales Share by Manufacturers in 2024
 Figure 24. Global Dermatological Medicine Revenue Share by Manufacturers in 2024
 Figure 25. Global 5 and 10 Largest Dermatological Medicine Players: Market Share by Revenue in Dermatological Medicine in 2024
 Figure 26. Dermatological Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Global Dermatological Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 28. North America Dermatological Medicine Sales Market Share by Country (2020-2031)
 Figure 29. North America Dermatological Medicine Revenue Market Share by Country (2020-2031)
 Figure 30. United States Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Canada Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Europe Dermatological Medicine Sales Market Share by Country (2020-2031)
 Figure 33. Europe Dermatological Medicine Revenue Market Share by Country (2020-2031)
 Figure 34. Germany Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. France Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. U.K. Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Italy Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Russia Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Asia Pacific Dermatological Medicine Sales Market Share by Region (2020-2031)
 Figure 40. Asia Pacific Dermatological Medicine Revenue Market Share by Region (2020-2031)
 Figure 41. China Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Japan Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. South Korea Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. India Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Australia Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. China Taiwan Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Indonesia Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Thailand Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Malaysia Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Dermatological Medicine Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Dermatological Medicine Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Dermatological Medicine Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Dermatological Medicine Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Dermatological Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Dermatological Medicine by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Dermatological Medicine by Type (2020-2031)
 Figure 62. Global Dermatological Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Dermatological Medicine by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Dermatological Medicine by Application (2020-2031)
 Figure 65. Global Dermatological Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 66. Dermatological Medicine Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture